NO750633L - - Google Patents
Info
- Publication number
- NO750633L NO750633L NO750633A NO750633A NO750633L NO 750633 L NO750633 L NO 750633L NO 750633 A NO750633 A NO 750633A NO 750633 A NO750633 A NO 750633A NO 750633 L NO750633 L NO 750633L
- Authority
- NO
- Norway
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0092—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by an OH group free esterified or etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8928/74A GB1499822A (en) | 1974-02-27 | 1974-02-27 | 2-bromo-6beta-fluoropregna-1,4-diene-3,20-diones |
GB2998474 | 1974-07-05 | ||
GB3294574 | 1974-07-25 | ||
GB4998274 | 1974-11-19 |
Publications (3)
Publication Number | Publication Date |
---|---|
NO750633L true NO750633L (da) | 1975-08-28 |
NO144527B NO144527B (no) | 1981-06-09 |
NO144527C NO144527C (no) | 1981-09-23 |
Family
ID=27447687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO750633A NO144527C (no) | 1974-02-27 | 1975-02-25 | Analogifremg.m. ved fremst. av anti-inflammatorisk virksomme estere av 2-brom-6beta,9alfa-difluor-11beta,16alfa,17alfa,21-tetrahydroksypregna- eller 2-brom-6beta,9alfa-difluor-11beta,17alfa,21-trihydroksypregna-1,4-dien-3,20-dioner |
Country Status (18)
Country | Link |
---|---|
JP (1) | JPS5614677B2 (da) |
AR (1) | AR218601A1 (da) |
BE (1) | BE826030A (da) |
CA (1) | CA1064476A (da) |
CH (1) | CH608243A5 (da) |
DE (3) | DE2508136C3 (da) |
DK (1) | DK144068C (da) |
ES (3) | ES435067A1 (da) |
FI (1) | FI56188C (da) |
FR (1) | FR2261776B1 (da) |
GB (1) | GB1499822A (da) |
IE (1) | IE42112B1 (da) |
LU (1) | LU71908A1 (da) |
NO (1) | NO144527C (da) |
NZ (1) | NZ176716A (da) |
RO (1) | RO78881A (da) |
SE (1) | SE410736B (da) |
YU (3) | YU108381A (da) |
-
1974
- 1974-02-27 GB GB8928/74A patent/GB1499822A/en not_active Expired
-
1975
- 1975-02-10 CA CA219,681A patent/CA1064476A/en not_active Expired
- 1975-02-14 FR FR7504616A patent/FR2261776B1/fr not_active Expired
- 1975-02-19 DK DK61575A patent/DK144068C/da not_active IP Right Cessation
- 1975-02-20 NZ NZ176716A patent/NZ176716A/xx unknown
- 1975-02-24 AR AR257732A patent/AR218601A1/es active
- 1975-02-24 IE IE379/75A patent/IE42112B1/en unknown
- 1975-02-25 CH CH232575A patent/CH608243A5/xx not_active IP Right Cessation
- 1975-02-25 NO NO750633A patent/NO144527C/no unknown
- 1975-02-25 DE DE2508136A patent/DE2508136C3/de not_active Expired
- 1975-02-25 ES ES435067A patent/ES435067A1/es not_active Expired
- 1975-02-25 FI FI750537A patent/FI56188C/fi not_active IP Right Cessation
- 1975-02-25 LU LU71908A patent/LU71908A1/xx unknown
- 1975-02-26 RO RO7581496A patent/RO78881A/ro unknown
- 1975-02-26 JP JP2298075A patent/JPS5614677B2/ja not_active Expired
- 1975-02-26 SE SE7502146A patent/SE410736B/xx unknown
- 1975-02-26 BE BE153787A patent/BE826030A/xx not_active IP Right Cessation
- 1975-07-25 DE DE2533377A patent/DE2533377C3/de not_active Expired
- 1975-07-25 DE DE2533323A patent/DE2533323C3/de not_active Expired
-
1977
- 1977-02-15 ES ES455934A patent/ES455934A1/es not_active Expired
- 1977-02-15 ES ES455933A patent/ES455933A1/es not_active Expired
-
1981
- 1981-04-27 YU YU01083/81A patent/YU108381A/xx unknown
- 1981-04-27 YU YU01082/81A patent/YU108281A/xx unknown
- 1981-04-27 YU YU01084/81A patent/YU108481A/xx unknown